Related Experiment Video
Updated: May 31, 2026

Murine Aortic Crush Injury: An Efficient In Vivo Model of Smooth Muscle Cell Proliferation and Endothelial Function
Published on: June 11, 2017
Induction of smooth muscle cell migration during arteriogenesis is mediated by Rap2
Jochen Pöling1, Marten Szibor, Silvia Schimanski
1Department of Cardiac Development and Remodelling, Max-Planck-Institute for Heart and Lung Research, Bad Nauheim, Germany.
Objective:
Collateral artery growth or arteriogenesis is the primary means of the circulatory system to maintain blood flow in the face of major arterial occlusions. Arteriogenesis depends on activation of fibroblast growth factor (FGF) receptors, but relatively little is known about downstream mediators of FGF signaling.
Methods And Results:
We screened for signaling components that are activated in response to administration of FGF-2 to cultured vascular smooth muscle cells (VSMCs) and detected a significant increase of Rap2 but not of other Ras family members, which corresponded to a strong upregulation of Rap2 and C-Raf in growing collaterals from rabbits with femoral artery occlusion. Small interfering RNAs directed against Rap2 did not affect FGF-2 induced proliferation of VSMC but strongly inhibited their migration. Inhibition of FGF receptor-1 (FGFR1) signaling by infusion of a sulfonic acid polymer or infection with a dominant-negative FGFR1 adenovirus inhibited Rap2 upregulation and collateral vessel growth. Similarly, expression of dominant-negative Rap2 blocked arteriogenesis, whereas constitutive active Rap2 enhanced collateral vessel growth.
Conclusions:
Rap2 is part of the arteriogenic program and acts downstream of the FGFR1 to stimulate VSMC migration. Specific modulation of Rap2 might be an attractive target to manipulate VSMC migration, which plays a role in numerous pathological processes.
Insights
Rap2, a signaling molecule, is crucial for collateral artery growth (arteriogenesis) by promoting vascular smooth muscle cell migration downstream of FGF receptor-1 signaling. Modulating Rap2 may offer therapeutic strategies.
Area of Science:
- Cardiovascular Biology
- Molecular Signaling
- Vascular Biology
Background:
- Arteriogenesis is vital for maintaining blood flow during arterial occlusions.
- Fibroblast Growth Factor (FGF) receptor signaling is key to arteriogenesis, but downstream mediators are poorly understood.
Purpose of the Study:
- To identify downstream mediators of FGF signaling in arteriogenesis.
- To investigate the role of Rap2 in fibroblast growth factor-induced vascular smooth muscle cell (VSMC) function and collateral artery growth.
Main Methods:
- Screening of signaling components activated by FGF-2 in cultured VSMCs.
- Utilizing small interfering RNAs (siRNAs) to inhibit Rap2 expression.
- Employing FGF receptor-1 (FGFR1) inhibition strategies (sulfonic acid polymer, dominant-negative FGFR1 adenovirus).
- Assessing the impact of Rap2 modulation (dominant-negative and constitutive active forms) on arteriogenesis in vivo.
Main Results:
- Rap2, but not other Ras family members, was significantly upregulated by FGF-2 in VSMCs and in growing collateral arteries.
- Rap2 inhibition via siRNA did not affect VSMC proliferation but strongly inhibited migration.
- FGFR1 inhibition blocked Rap2 upregulation and collateral vessel growth.
- Dominant-negative Rap2 expression inhibited arteriogenesis, while constitutive active Rap2 enhanced it.
Conclusions:
- Rap2 functions downstream of FGFR1 within the arteriogenic signaling pathway.
- Rap2 specifically promotes VSMC migration, a critical component of arteriogenesis.
- Targeting Rap2 presents a potential therapeutic avenue for conditions involving VSMC migration.
Related Concept Videos
Regulation of Angiogenesis and Blood Supply
MAPK Signaling Cascades
Mechanism of Angiogenesis
Intracellular Signaling Affects Focal Adhesions
Some...
Cell Migration
Cell Migration

